• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 10
  3. Author

Online ISSN: 2515-8260

Volume7, Issue10

THE CHINESE PRIVATE MEDICAL SERVICE PROVIDERS: A REVIEW

    Yuaner Ma, Juhaini Jabar

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 10, Pages 1902-1912

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In the past 20 years, the number of private medical institutions in China has increased rapidly, the technology has been upgraded and the scale has been expanded. Domestic medical service giants, specialty chains, international medical and diversified institutions have entered the private sector. The trend of value-based healthcare is emerging. The diversified pattern of running hospitals has taken shape. The global trend of value-based healthcare has also brought opportunities for differentiated development of private medical institutions in China, which promotes the transformation from "quantitative change" to "qualitative change". The influx of diversified social capital helps the expansion and integration of medium and high-end private hospitals. The investment in private hospitals and public hospitals in China's capital market has shown an unprecedented growth; the diversified capital structure composed of investment institutions, pharmaceutical groups, insurance funds and pharmaceutical related industrial chain enterprises has become the core driving force for the sustainable development of China's private medical institutions.
 
Keywords:
  • PDF (275 K)
  • XML
(2021). THE CHINESE PRIVATE MEDICAL SERVICE PROVIDERS: A REVIEW. European Journal of Molecular & Clinical Medicine, 7(10), 1902-1912.
Yuaner Ma, Juhaini Jabar. "THE CHINESE PRIVATE MEDICAL SERVICE PROVIDERS: A REVIEW". European Journal of Molecular & Clinical Medicine, 7, 10, 2021, 1902-1912.
(2021). 'THE CHINESE PRIVATE MEDICAL SERVICE PROVIDERS: A REVIEW', European Journal of Molecular & Clinical Medicine, 7(10), pp. 1902-1912.
THE CHINESE PRIVATE MEDICAL SERVICE PROVIDERS: A REVIEW. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 1902-1912.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 39
  • PDF Download: 100
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus